Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: Correlation with cardiac MR

Open Heart

Volumn 1, Issue 1, 2014, Pages

  Suwa, Kenichiro ^a,b,c,d,e,f   Satoh, Hiroshi ^{a,b,c,d,e,f,g}   Sano, Makoto ^a,b,c,d,e,f   Nobuhara, Mamoru ^a,b,c,d,e,f   Saitoh, Takeji ^a,b,c,d,e,f   Saotome, Masao ^a,b,c,d,e,f   Urushida, Tsuyoshi ^a,b,c,d,e,f   Katoh, Hideki ^a,b,c,d,e,f   Tawarahara, Kei ^a,b,c,d,e,f   Ohtani, Hayato ^a,b,c,d,e,f   Wakabayashi, Yasushi ^a,b,c,d,e,f   Takase, Hiroyuki ^a,b,c,d,e,f   Terada, Hajime ^a,b,c,d,e,f   Takehara, Yasuo ^g   Sakahara, Harumi ^g   Hayashi, Hideharu ^a,b,c,d,e,f  

^a Investigator Group   (Japan)

^b Enshu Hospital   (Japan)

^c HAMAMATSU UNIVERSITY HOSPITAL   (Japan)

^d Hamamatsu Red Cross Hospital   (Japan)

^e Kosai General Hospital   (Japan)

^f Seirei Mikatahara Hospital   (Japan)

^g HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM PENTETATE DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CINE MAGNETIC RESONANCE IMAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEART ANEURYSM; HEART ARRHYTHMIA; HEART CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTERMETHOD COMPARISON; MALE; METHODOLOGY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOLOGICAL ANATOMY; PREVALENCE; QRS COMPLEX; SCAR; SENSITIVITY AND SPECIFICITY; ST SEGMENT DEPRESSION; T WAVE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 84984598140     PISSN: None     EISSN: 20533624     Source Type: Journal    
DOI: 10.1136/openhrt-2014-000124     Document Type: Article

References (30)

1. Sakamoto T, Tei C, Murayama M, et al. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle: echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J 1976;17:611-29.
2. Yamaguchi H, Ishimura T, Nishiyama S, et al. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979;44:401-12.
3. Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39:638-45.
4. Maron MS, Finley JJ, Bos JM, et al. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008;118:1541-9.
5. Chung T, Yiannikas J, Freedman SB, et al. Unusual features of apical hypertrophic cardiomyopathy. Am J Cardiol 2010;105:879-83.
6. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
7. Moon JCC, Fisher NG, McKenna WJ, et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography. Heart 2004;90:645-9.
8. Tseng WY, Dou J, Reese TG, et al. Imaging myocardial fiber disarray and intramural strain hypokinesis in hypertrophic cardiomyopathy with MRI. J Magn Reson Imaging 2006;23:1-8.
9. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855-61.
10. Matoh F, Satoh H, Shiraki K, et al. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Card Fail 2007;13:372-9.
11. Adabag AS, Maron BJ, Appelbaum E, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008;51:1369-74.
12. Rubinshtein R, Glockner JF, Ommen SR, et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010;3:51-8.
13. Fattori R, Biagini E, Lorenzini ML, et al. Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. Am J Cardiol 2010;105:1592-6.
14. Sato T, Nakamura K, Yamanari H, et al. Relationship between electrocardiographic features and distribution of hypertrophy in patients with hypertrophic cardiomyopathy. Jpn Cric J 1998;62:483-8.
15. Satoh H, Matoh F, Shiraki K, et al. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy. J Card Fail 2009;15:419-27.
16. Das MK, Khan B, Sony Jacob S, et al. Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease. Circulation 2006;113:2495-501.
17. Pietrasik G, Goldenberg I, Zdzienicka J, et al. Prognostic significance of fragmented QRS complex for predicting the risk of recurrent cardiac events in patients with Q-wave myocardial infarction. Am J Cardiol 2007;100:583-6.
18. Natsume T, Amano T, Takehara Y, et al. Quantitative assessment of regional systolic and diastolic functions and temporal heterogeneity of myocardial contraction in patients with myocardial infarction using cine magnetic resonance imaging and Fourier fitting. Magn Reson Imaging 2009;27:1440-6.
19. Reddy V, Korcarz C, Weinert L, et al. Apical hypertrophic cardiomyopathy. Circulation 1998;98:2354.
20. Ennezat PV, Mouquet F. Hypertrophic cardiomyopathy associated with left ventricular apical aneurysm. Arch Cardiovasc Dis 2010;103:198-9.
21. Matsubara K, Nakamura T, Kuribayashi T, et al. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;42:288-95.
22. Kubo T, Kitaoka H, Okawa M, et al. Clinical profiles of hypertrophic cardiomyopathy with apical phenotype - comparison of pure-apical form and distal-dominant form. Circ J 2009;73:2330-6.
23. Moon JCC, McKenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7.
24. Kim RJ, Judd RM. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death? J Am Coll Cardiol 2003;41:1568-72.
25. Dumont CA, Monserrat L, Soler R, et al. Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J 2006;27:1725-31.
26. Koga Y, Katoh A, Matsuyama K, et al. Disappearance of giant negative T waves in patients with the Japanese form of apical hypertrophy. J Am Coll Cardiol 1995;26:1672-8.
27. Hata S, Shikuwa M, Yamasa T, et al. The left ventriculographic pattern and serial electrocardiographic changes in hypertrophic cardiomyopathy patients with giant negative T waves. Cardiology 1996;87:365-73.
28. Alfonso F, Nihoyannopoulos P, Stewart J, et al. Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990;15:965-71.
29. Chen X, Zhao T, Lu M, et al. The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 2014;30(Suppl 1):55-63.
30. Holloway CJ, Betts TR, Naubauer S, et al. Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia. J Am Coll Cardiol 2010;56:1961.